Navigation Links
3-V Biosciences Completes $20 Million Series C Financing
Date:6/21/2013

synergy of its FASN-inhibitors with cytotoxic agents. 3-V plans to file an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) in the third quarter and initiate first-in-human studies by the end of 2013.

"The team at 3-V has done an impressive job of generating a pipeline of novel therapeutic product candidates with promising activity in diverse oncology and infectious disease indications," said David Mott, General Partner of New Enterprise Associates and Chairman of the Board of 3-V Biosciences. "We are pleased to support 3-V's continued efforts as they advance their lead program into clinical development."

3-V is leveraging its screening platform, drug discovery and drug development capabilities to identify antiviral candidates that exploit the dependence of the virus on the host cell by blocking host-virus interactions. The leads in the company's pipeline are characterized by their novel mechanism of action, broad-spectrum antiviral activity and high barrier to resistance. 3-V is currently evaluating antiviral therapeutic candidates for respiratory syncytial virus (RSV), herpes simplex virus (HSV) and hepatitis C virus (HCV).

About 3-V Biosciences
3-V Biosciences, Inc. is a privately held biopharmaceutical company discovering and developing therapeutics that modulate key pathways in oncology and infectious disease. In oncology, the company's lead candidate is a fatty acid synthase (FASN) inhibitor that blocks tumor cell signaling pathways and induces tumor cell apoptosis. 3-V's antiviral therapeutics block host-pathogen interactions, resulting in robust and broad-spectrum antiviral activity, including efficacy against viruses resistant to other classes of antiviral drugs, and a high barrier to resistance. The 3-V team applies an integrated approach, leveraging internal expertise in biology, medicinal chemistry, drug discovery and development to drive programs forward. T
'/>"/>

SOURCE 3-V Biosciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
3. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
4. Neurocrine Biosciences Reports First Quarter 2012 Results
5. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
7. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
8. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
9. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
10. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
11. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Scientific Corporation (NYSE: BSX ) will webcast a conference ... to review financial results and business highlights for the first ... first quarter financial results prior to the conference call. ... , president and chief executive officer, and Dan Brennan ... A live webcast of the conference call will be available ...
(Date:4/1/2015)... BURNIE, Md. , April 1, 2015 /PRNewswire/ ... patient recruitment solutions for the clinical research industry, ... help with a dermatology study that was falling ... expert recruitment strategies and customized site support programs, ... screening and enrolling, and also increased the number ...
(Date:4/1/2015)... CREEK, Calif. , April 1, 2015  For ... huge difference.  When this is the case, having the ... No one understands this truth better than software solutions ... laboratory management software QATrax.  Recently, the company announced the ... very enthusiastic response from clients. ...
Breaking Medicine Technology:Boston Scientific To Webcast Conference Call On First Quarter 2015 Financial Results 2CSSi Quadruples Screening Activity and Speeds Enrollment for Pediatric Dermatology Study 2TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2
... , RESEARCH TRIANGLE PARK, N.C. , ... ) announced today that the U.S. Food and Drug Administration ... add-on therapy for epilepsy in patients ages 13 years and ... label, as Lamictal XR is approved ...
... , , JOHNSTOWN, Pa. , Jan. 29 ... Company), (Pink Sheets: EPGL), ( www.eparent.com ), the parent company ... announce that Stephen L. DeFelice , MD, has joined the EPGL ... nutraceutical products and is credited for introducing the term "nutraceutical."  , ...
Cached Medicine Technology:FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures 2FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures 3FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures 4FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures 5FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures 6FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures 7EP Global Communications, Inc. Welcomes Stephen DeFelice, MD, to Advisory Board 2EP Global Communications, Inc. Welcomes Stephen DeFelice, MD, to Advisory Board 3
(Date:4/1/2015)... Pricing Healthcare has added facilities to ... coverage to a third of all US states. The ... and Iowa, and the first dedicated eye center in the country ... was also added. , In addition, the site reached a milestone ... in the platform continue to grow across the country. , 1. ...
(Date:4/1/2015)... With so much wet weather over the past few months, ... indoors. When all this time is spent inside, it is ... from Clean Crawls offers excellent advice to homeowners seeking ... One of the ways to improve the air quality in ... states that, “Toluene, Xylene, and Benzene are all Volatile Organic ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 "Giving credit ... to form. Its rewards are inestimable." - Loretta Young ... individuals in the water resources profession. The Call ... Please consider nominating yourself, a colleague, or organization for ... 2015. Learn more about the AWRA Awards and view ...
(Date:4/1/2015)... 01, 2015 Decora Preset 30 Minute Countdown ... on ‘The Hardware City.’ The product helps in automatically switching ... time and the related electronic device is automatically turned off ... the company said, “We are glad that this amazing product ... buy Countdown Timer Switch in just a few clicks. The ...
(Date:4/1/2015)... April 01, 2015 TCS Healthcare Technologies ... for the care management and population health arenas, is ... portal Acuity Connect, which is fully integrated with the ... 2015 at 1:30 p.m. ET, will be led by ... TCS. It will explore the feature-rich portal as well ...
Breaking Medicine News(10 mins):Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 2Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 3Health News:3 Simple Ways to Improve Home Air Quality Listed by Clean Crawls in Latest Article 2Health News:Nominations Sought for National Water Resources Awards and Student Scholarships 2Health News:Nominations Sought for National Water Resources Awards and Student Scholarships 3Health News:Leviton Decora Preset 30 Minute Countdown Timer Available On TheHardwareCity.com 2Health News:TCS Healthcare Technologies Releases Acuity Connect 2Health News:TCS Healthcare Technologies Releases Acuity Connect 3
... Promising and Replicable,Solutions For Lowering Costs, Improving Quality ... When a large urban hospital in,Florida put ... for a designated unit of patients, it dramatically ... satisfaction levels among,patients and staff. The story of ...
... April 16 Law Offices of Howard ... claims against Inverness,Medical Innovations, Inc. ("Inverness Medical" ... law violations by Inverness Medical and,certain of ... secondary,public offering on or about November 14, ...
... 16 IC Sciences Corporation announced,today a ... designing and,developing informatics instruments used in medical ... emerging field that draws upon the,cognitive and ... and,experimental foundation regarding human intelligence,s reliance on,narrative ...
... 5284 & H.B. 5285 Enables BCBSM to expand ... its Monopoly rather than Lower Rates, LANSING, ... enable the Blues to expand their unfair advantage into,a monopoly rather ... Fair & Competitive Insurance Market. The Coalition,represents a group of Michigan ...
... Finds Employer Threatened, Misled Workers at Stockton Retirement,Home, ... Relations Board has recommended a new election be ... after finding management,violated federal law by threatening and ... union election in November., Workers at O,Connor ...
... (April 16, 2008) A new discovery by University ... of how the spinal cord controls how people walk. ... central nervous system maladies such as Parkinson,s disease and ... Ph.D., and Karen Mesce, Ph.D., in the Departments of ...
Cached Medicine News:Health News:New Website Showcases 24 Promising Models That Are Transforming How Health Care Is Delivered 2Health News:New Website Showcases 24 Promising Models That Are Transforming How Health Care Is Delivered 3Health News:New Website Showcases 24 Promising Models That Are Transforming How Health Care Is Delivered 4Health News:IC Sciences Investigates Application of Narrative Sciences for Medical Informatics Instruments 2Health News:IC Sciences Investigates Application of Narrative Sciences for Medical Informatics Instruments 3Health News:Coalition For A Fair & Competitive Insurance Market Says Senate Should Reject the Blues Attempt to Expand Their Unfair Advantage 2Health News:Coalition For A Fair & Competitive Insurance Market Says Senate Should Reject the Blues Attempt to Expand Their Unfair Advantage 3Health News:Coalition For A Fair & Competitive Insurance Market Says Senate Should Reject the Blues Attempt to Expand Their Unfair Advantage 4Health News:NLRB Orders New Union Election at O'Connor Woods 2Health News:U of M researchers identify process that may help treat Parkinson's, spinal cord injuries 2
... a 16kDa peptide encoded by the ob gene ... believed to play a key role in the ... and expenditure [1,2]. Leptin functions as a lipostat ... increasing fat stores. Increased serum leptin levels signal ...
ACTIVATED CLOTTING TIME SYSTEM...
... Maximum image quality, accuracy and versatility. ... ACP Technology™, via our exclusive mPower™ whole ... is optimized to yield the highest quality ... In addition, the mPower™ is the only ...
... Human chorionic gonadotropin (hCG) is a two ... by the chorionic tissue of the placenta ... blood during pregnancy. Produced by the trophoblastic ... maintain the corpus luteum in the early ...
Medicine Products: